An interventional study of Mindfulness Based Compassionate Living in Recurrent Depression, sponsored by Radboud University Medical Center. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-18.
Sponsored by Radboud University Medical Center · Not applicable, Interventional, and Treatment
Since a few years, Mindfulness Based Cognitive Therapy (MBCT) has been used as treatment for patients suffering from recurrent depression. Though a number of studies show that MBCT is effective in this population and MBCT reduces the chances of relapse/recurrence in recurrent depressive patients, the chance of a new depression developing after end of treatment is still considerable. Ergo, there is room for improvement.
Especially the development of a non-judging or compassionate attitude towards all experience seems to mediate the treatment effect. It is therefore our expectation that a follow-up intervention that focuses specifically on self-compassion could prove very useful in elaborating on the effects of MBCT.
The research question of this research is therefore: what is the effect of compassion training in people suffering from recurrent depression who have already received MBCT training?
4,279 studies on the registry are indexed under Recurrence; 988 are open to participants now.
This study's enrollment of 122 is above the median of 50 across 3,374 interventional studies indexed under Recurrence.
Browse Recurrence studies →Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This cohort receives the Mindfulness Based Compassionate Living program in addition to treatment as usual.
Behavioral: Mindfulness Based Compassionate Living
This cohort receives treatment as usual of any nature, e.g. psychotherapy, antidepressant medication etc.
The MBCL program consists of eight biweekly group sessions of 2.5 hours, in which the participants get formal meditation exercises, some theoretical information and participate in inquiry on the meditation exercises and homework assignments. Homework assignments are given after every session, consisting of formal and informal meditation exercises primarily and some diary instructions.
Also known as: MBCL, Mindfulness Based Compassion Training
Beck Depression Inventory-II
The BDI-II measures depression symptoms. Measurements will be taken at baseline, end of treatment/control and follow up.
Time frame: 1 year
Self-Compassion Scale
The Self-Compassion Scale measures Self-Compassion. Measurements will be taken at baseline, end of treatment/control and follow-up.
Time frame: 1 year
Five Facet Mindfulness Questionnaire
The FFMQ measures mindfulness skills. Measurements will be taken at baseline, end of treatment/control and follow-up.
Time frame: 1 year
The Acceptance and Action Questionnaire-II
The AAQ-II measures Experiential Avoidance. Measurements will be taken at baseline, end of treatment/control and follow-up.
Time frame: 1 year
Fears of Compassion Scale (3)
The FoCS (3) measures fear of Self-Compassion. Measurements will be taken at baseline, end of treatment/control and follow-up.
Time frame: 1 year
Types of Positive Affect Scale
The TPAS measures Positive Affect. Measurements will be taken at baseline, end of treatment/control and follow-up.
Time frame: 1 year
The World Health Organization Quality of Life Scale
The WHO-QoL measures Quality of Life. Measurements will be taken at baseline, end of treatment/control and follow-up.
Time frame: 1 year
The Ruminative Response Scale
The RRS measures Rumination. Measurements will be taken at baseline, end of treatment/control and follow-up.
Time frame: 1 year
The Childhood Trauma Questionnaire
The CTQ measures Childhood Adversity. Measurements will be taken at baseline only.
Time frame: Baseline
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Radboud University Medical Center